Su, Shao-Hua <br/><br/>
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.  [electronic resource] 

 -  Naunyn-Schmiedeberg's archives of pharmacology  Dec 2017 
 - 1189-1200 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1912 
<br/><br/><label>Standard No.: </label>10.1007/s00210-017-1417-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidohydrolases--antagonists & inhibitors<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Benzamides--pharmacology<br/>Benzoxazines--pharmacology<br/>Cannabinoid Receptor Agonists--pharmacology<br/>Carbamates--pharmacology<br/>Cerebrovascular Disorders--drug therapy<br/>Endocannabinoids--physiology<br/>Hippocampus--drug effects<br/>Macrophage Activation--drug effects<br/>Male<br/>Morpholines--pharmacology<br/>NF-kappa B--antagonists & inhibitors<br/>Naphthalenes--pharmacology<br/>Neuritis--drug therapy<br/>Prefrontal Cortex--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects<br/>Transcription Factor RelA--drug effects